Adverse events230

Each adverse event the trial posted, group by group: the participants affected out of those at risk.

1 to 20 of 230

Type	Event	Organ system	Group	Affected	At risk	Events
other	Abdominal pain	Gastrointestinal disorders	PF-03084014 in Desmoid Tumors/Aggressive Fibromatosis	8	17	11
other	Activated partial thromboplastin time prolonged	Investigations	PF-03084014 in Desmoid Tumors/Aggressive Fibromatosis	4	17	6
other	Alanine aminotransferase increased	Investigations	PF-03084014 in Desmoid Tumors/Aggressive Fibromatosis	9	17	35
other	Alkaline phosphatase increased	Investigations	PF-03084014 in Desmoid Tumors/Aggressive Fibromatosis	5	17	16
other	Allergic rhinitis	Immune system disorders	PF-03084014 in Desmoid Tumors/Aggressive Fibromatosis	2	17	2
other	Alopecia	Skin and subcutaneous tissue disorders	PF-03084014 in Desmoid Tumors/Aggressive Fibromatosis	2	17	2
other	Amnesia	Nervous system disorders	PF-03084014 in Desmoid Tumors/Aggressive Fibromatosis	1	17	1
other	Anemia	Blood and lymphatic system disorders	PF-03084014 in Desmoid Tumors/Aggressive Fibromatosis	9	17	23
other	Anorexia	Metabolism and nutrition disorders	PF-03084014 in Desmoid Tumors/Aggressive Fibromatosis	3	17	3
other	Anxiety	Psychiatric disorders	PF-03084014 in Desmoid Tumors/Aggressive Fibromatosis	3	17	4
other	Arthralgia	Musculoskeletal and connective tissue disorders	PF-03084014 in Desmoid Tumors/Aggressive Fibromatosis	2	17	2
other	Arthritis	Musculoskeletal and connective tissue disorders	PF-03084014 in Desmoid Tumors/Aggressive Fibromatosis	1	17	1
other	Aspartate aminotransferase increased	Investigations	PF-03084014 in Desmoid Tumors/Aggressive Fibromatosis	12	17	32
other	Atrial fibrillation	Cardiac disorders	PF-03084014 in Desmoid Tumors/Aggressive Fibromatosis	1	17	1
other	Back pain	Musculoskeletal and connective tissue disorders	PF-03084014 in Desmoid Tumors/Aggressive Fibromatosis	5	17	11
other	Bloating	Gastrointestinal disorders	PF-03084014 in Desmoid Tumors/Aggressive Fibromatosis	1	17	1
other	Blood bilirubin increased	Investigations	PF-03084014 in Desmoid Tumors/Aggressive Fibromatosis	3	17	18
other	Blood gonadotrophin abnormal	Investigations	PF-03084014 in Desmoid Tumors/Aggressive Fibromatosis	1	17	1
other	Blurred vision	Eye disorders	PF-03084014 in Desmoid Tumors/Aggressive Fibromatosis	3	17	3
other	Bronchial infection	Infections and infestations	PF-03084014 in Desmoid Tumors/Aggressive Fibromatosis	1	17	5

Source ClinicalTrials.govtrials-2026-11-12-0.5.0

ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
ClinicalTrials.govNo license stated
NIH RePORTER's clinical studies and project filesPublic domain

Each source's terms

ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
ClinicalTrials.govnone stated
NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this list from software.

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/trials/v1/NCT01981551/events

API reference For AI assistants

Adverse events230

Sources 3

Read this list from software.